Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17354 | 603 | 36.5 | 42% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
658 | 3 | COENZYME Q10//UBIQUINONE//COENZYME Q | 11100 |
2319 | 2 | SENESCENCE ACCELERATED MOUSE//SAMP8//SENESCENCE ACCELERATED MOUSE SAM | 4476 |
17354 | 1 | MEMBRANE HYPOTHESIS OF AGING//VILEGHUNGARIAN SECT//PROTEIN LATERAL MOBILITY | 603 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MEMBRANE HYPOTHESIS OF AGING | authKW | 253189 | 1% | 100% | 5 |
2 | VILEGHUNGARIAN SECT | address | 253189 | 1% | 100% | 5 |
3 | PROTEIN LATERAL MOBILITY | authKW | 202551 | 1% | 100% | 4 |
4 | HEPATOCYTE PLASMA MEMBRANE | authKW | 182291 | 1% | 60% | 6 |
5 | FRAP TECHNIQUE | authKW | 151914 | 0% | 100% | 3 |
6 | OH CENTER DOT FREE RADICALS | authKW | 151914 | 0% | 100% | 3 |
7 | ST S PROPHYLAXIS | address | 135032 | 1% | 67% | 4 |
8 | ANTAGONIC STRESS | authKW | 101276 | 0% | 100% | 2 |
9 | ANTISTRESS AND ANTIAGING THERAPY | authKW | 101276 | 0% | 100% | 2 |
10 | BCE 001 | authKW | 101276 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Geriatrics & Gerontology | 33356 | 40% | 0% | 241 |
2 | Pharmacology & Pharmacy | 834 | 23% | 0% | 141 |
3 | Cell Biology | 316 | 13% | 0% | 81 |
4 | Toxicology | 197 | 6% | 0% | 37 |
5 | Gerontology | 195 | 2% | 0% | 15 |
6 | Biochemistry & Molecular Biology | 77 | 14% | 0% | 84 |
7 | Medicine, Research & Experimental | 57 | 5% | 0% | 29 |
8 | Biophysics | 42 | 4% | 0% | 25 |
9 | Medicine, General & Internal | 29 | 5% | 0% | 30 |
10 | Biology | 19 | 2% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VILEGHUNGARIAN SECT | 253189 | 1% | 100% | 5 |
2 | ST S PROPHYLAXIS | 135032 | 1% | 67% | 4 |
3 | GERONTOLVILEG HUNGARIAN SECT | 101276 | 0% | 100% | 2 |
4 | PL PHYSIOL MOL BIOL | 90018 | 1% | 44% | 4 |
5 | VILEG HUNGARIAN SECT | 67516 | 0% | 67% | 2 |
6 | BIOCHEM ENDOCRINOL AGING | 50638 | 0% | 100% | 1 |
7 | BIOMEMBRANE PROGRAM | 50638 | 0% | 100% | 1 |
8 | GERNTOL | 50638 | 0% | 100% | 1 |
9 | GERONTOL VILEG ITALIAN SECT | 50638 | 0% | 100% | 1 |
10 | HUNGARIAN SECT | 50638 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MECHANISMS OF AGEING AND DEVELOPMENT | 58580 | 11% | 2% | 68 |
2 | ARCHIVES OF GERONTOLOGY AND GERIATRICS | 35927 | 8% | 1% | 50 |
3 | EXPERIMENTAL GERONTOLOGY | 10622 | 5% | 1% | 28 |
4 | AGE | 6671 | 2% | 1% | 13 |
5 | GERONTOLOGY | 5419 | 2% | 1% | 15 |
6 | AGE AND AGEING | 3869 | 3% | 0% | 16 |
7 | ACTA BIOLOGICA ET MEDICA GERMANICA | 1587 | 1% | 1% | 4 |
8 | DRUG METABOLISM AND DISPOSITION | 1301 | 2% | 0% | 14 |
9 | JOURNAL OF THE AMERICAN AGING ASSOCIATION | 1053 | 0% | 2% | 1 |
10 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 786 | 1% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NAGY, IZ , (2002) PHARMACOLOGICAL INTERVENTIONS AGAINST AGING THROUGH THE CELL PLASMA MEMBRANE - A REVIEW OF THE EXPERIMENTAL RESULTS OBTAINED IN ANIMALS AND HUMANS.INCREASING HEALTHY LIFE SPAN: CONVENTIONAL MEASURES AND SLOWING THE INNATE AGING PROCESS. VOL. 959. ISSUE . P. 308 -320 | 24 | 92% | 2 |
2 | DAMJANOVICH, S , NAGY, IZ , GASPAR, R , (2001) EXPERIMENTAL GERONTOLOGY IN HUNGARY.EXPERIMENTAL GERONTOLOGY. VOL. 37. ISSUE 1. P. 9 -17 | 32 | 55% | 0 |
3 | KITANI, K , (1999) LATERAL MOBILITY OF PROTEINS AND LIPIDS OF CELL SURFACE MEMBRANES DURING AGING: DO THE DATA SUPPORT 'THE MEMBRANE HYPOTHESIS OF AGING'?.MECHANISMS OF AGEING AND DEVELOPMENT. VOL. 107. ISSUE 3. P. 299 -322 | 24 | 77% | 7 |
4 | KITANI, K , (1994) AGING AND THE LIVER - FUNCTIONAL-ASPECTS.ARCHIVES OF GERONTOLOGY AND GERIATRICS. VOL. 19. ISSUE 2. P. 145-158 | 31 | 70% | 14 |
5 | KITANI, K , (2007) WHAT REALLY DECLINES WITH AGE? THE HAYFLICK LECTURE FOR 2006 35TH AMERICAN AGING ASSOCIATION.AGE. VOL. 29. ISSUE 1. P. 1 -14 | 25 | 52% | 5 |
6 | BIRNBAUM, LS , (1991) PHARMACOKINETIC BASIS OF AGE-RELATED-CHANGES IN SENSITIVITY TO TOXICANTS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 31. ISSUE . P. 101-128 | 59 | 34% | 33 |
7 | ZS-NAGY, I , (2002) ON THE REALITY AND POSSIBILITIES OF PHARMACOLOGICAL ANTI-AGING INTERVENTIONS TO SUPPORT SUCCESSFUL AGING.ARCHIVES OF GERONTOLOGY AND GERIATRICS. VOL. . ISSUE . P. 385-398 | 15 | 94% | 0 |
8 | BIRNBAUM, LS , (1987) AGE-RELATED-CHANGES IN CARCINOGEN METABOLISM.JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. VOL. 35. ISSUE 1. P. 51-60 | 38 | 67% | 14 |
9 | ZSNAGY, I , (1994) A SURVEY OF THE AVAILABLE DATA ON A NEW NOOTROPIC DRUG, BCE-001.PHARMACOLOGY OF AGING PROCESSES: METHODS OF ASSESSMENT AND POTENTIAL INTERVENTIONS. VOL. 717. ISSUE . P. 102 -114 | 19 | 83% | 11 |
10 | ZSNAGY, I , (1991) THE HORIZONS OF AN INTERDISCIPLINARY SYNTHESIS IN EXPERIMENTAL GERONTOLOGY.ARCHIVES OF GERONTOLOGY AND GERIATRICS. VOL. 12. ISSUE 2-3. P. 329-349 | 25 | 71% | 6 |
Classes with closest relation at Level 1 |